Lupin to distribute Eli Lilly’s diabetes drug in India

Pharmaceuticals maker Lupin said it will distribute US-based Eli Lilly and Co’s Aplevant (dulaglutide), a once-weekly injection for type 2 diabetes treatment. Lupin said it expects to make Aplevant available in India this month itself. The two companies already have a partnership dating back to 2011. With this, said Lupin, the partnership has been expanded […]

Cipla to sell Eli Lilly’s Basaglar insulin in India

Indian pharmaceutical giant Cipla Ltd said it would sellĀ Eli Lilly and Co’s insulin glargine in India. InsulinĀ glargine is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. Unlike regular insulin shots — which have to be taken multiple times a day — basal insulin releases […]

Zydus Cadila gets USFDA nod to launch generic version of billion-dollar drug Cialis eventually

The United States Food and Drug Administration has given Zydus Cadila approval to launch a generic version of the billion-dollar erectile dysfunction drug Cialis when patents expire. The patents are expected to expire in September next year. Cialis and Viagra are the most popular erectile dysfuntion drugs in the world. Cialis, created by Eli Lilly, […]